ESTA Stock Overview
A medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgeries. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Establishment Labs Holdings Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$33.92 |
| 52 Week High | US$60.12 |
| 52 Week Low | US$26.56 |
| Beta | 0.73 |
| 1 Month Change | 11.80% |
| 3 Month Change | 12.50% |
| 1 Year Change | -39.39% |
| 3 Year Change | -38.93% |
| 5 Year Change | 106.33% |
| Change since IPO | 37.05% |
Recent News & Updates
Recent updates
The Price Is Right For Establishment Labs Holdings Inc. (NASDAQ:ESTA) Even After Diving 26%
Apr 22
Here's Why Establishment Labs Holdings (NASDAQ:ESTA) Can Afford Some Debt
Apr 09What Is Establishment Labs Holdings Inc.'s (NASDAQ:ESTA) Share Price Doing?
Mar 19Establishment Labs Holdings Inc. (NASDAQ:ESTA) Annual Results Just Came Out: Here's What Analysts Are Forecasting For This Year
Mar 01After Leaping 29% Establishment Labs Holdings Inc. (NASDAQ:ESTA) Shares Are Not Flying Under The Radar
Feb 28Establishment Labs Holdings Inc. (NASDAQ:ESTA) Shares Slammed 27% But Getting In Cheap Might Be Difficult Regardless
Jan 14Is Establishment Labs Holdings Inc. (NASDAQ:ESTA) Trading At A 21% Discount?
Nov 25Is Establishment Labs Holdings (NASDAQ:ESTA) Using Too Much Debt?
Sep 23Earnings Release: Here's Why Analysts Cut Their Establishment Labs Holdings Inc. (NASDAQ:ESTA) Price Target To US$59.86
Aug 11Shareholders Should Be Pleased With Establishment Labs Holdings Inc.'s (NASDAQ:ESTA) Price
Jul 23Establishment Labs: Catalysts Supporting A Perky Outlook
Jan 28Is Establishment Labs Holdings (NASDAQ:ESTA) A Risky Investment?
Dec 08Is Establishment Labs Holdings (NASDAQ:ESTA) Using Too Much Debt?
Aug 10Shareholders Should Be Pleased With Establishment Labs Holdings Inc.'s (NASDAQ:ESTA) Price
Apr 17Establishment Labs Holdings (NASDAQ:ESTA) Is Carrying A Fair Bit Of Debt
Dec 14Establishment Labs drops 18% after new short report from Hindenburg Research
Oct 19Establishment Labs: Flat Earnings, Return On Investment Keep Buyers At Bay
Sep 24Shareholder Returns
| ESTA | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 1.6% | 0.09% | -0.3% |
| 1Y | -39.4% | 7.7% | 8.1% |
Return vs Industry: ESTA underperformed the US Medical Equipment industry which returned 7.5% over the past year.
Return vs Market: ESTA underperformed the US Market which returned 8% over the past year.
Price Volatility
| ESTA volatility | |
|---|---|
| ESTA Average Weekly Movement | 14.9% |
| Medical Equipment Industry Average Movement | 9.7% |
| Market Average Movement | 8.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 4.2% |
Stable Share Price: ESTA's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: ESTA's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 1,018 | Peter Caldini | www.establishmentlabs.com |
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgeries. The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders.
Establishment Labs Holdings Inc. Fundamentals Summary
| ESTA fundamental statistics | |
|---|---|
| Market cap | US$980.57m |
| Earnings (TTM) | -US$89.10m |
| Revenue (TTM) | US$170.24m |
5.8x
P/S Ratio-11.0x
P/E RatioIs ESTA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ESTA income statement (TTM) | |
|---|---|
| Revenue | US$170.24m |
| Cost of Revenue | US$57.28m |
| Gross Profit | US$112.95m |
| Other Expenses | US$202.06m |
| Earnings | -US$89.10m |
Last Reported Earnings
Mar 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -3.08 |
| Gross Margin | 66.35% |
| Net Profit Margin | -52.34% |
| Debt/Equity Ratio | 571.6% |
How did ESTA perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/11 16:45 |
| End of Day Share Price | 2025/05/09 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Establishment Labs Holdings Inc. is covered by 14 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Neil Chatterji | B. Riley Securities, Inc. |
| Marie Thibault | BTIG |
| Michael Gorman | BTIG |